Status:
RECRUITING
Clinical Diagnosis and Pathological Spectrum of Porto-sinusoidal Vascular Disease in India
Lead Sponsor:
Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions:
Portal Hypertension
Budd-Chiari Syndrome
Eligibility:
All Genders
12-70 years
Brief Summary
There is a need to re-evaluate the patients classified as NCPH and determine whether the new histological classification proposed by the VALDIG applies to the Indian scenario. We intend to identify th...
Detailed Description
Portal hypertension is clinically characterized by a portal venous pressure gradient between the inferior vena cava and the portal vein is more than 5 mm. Liver cirrhosis remains the leading cause of ...
Eligibility Criteria
Inclusion
- Patients of 12-70 years, either gender with clinical, pathological radiological diagnosis of NCPH
Exclusion
- Any patients having Cirrhosis based on clinical, pathological, or radiological diagnosis
- Any patients having active malignancy
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT06054451
Start Date
August 1 2023
End Date
June 1 2024
Last Update
April 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Madhumita Premkumar
Sector-12, Chandigarh, India, 160012